Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ilsel D. Lopez Armenta"'
Autor:
Cecilia Bonolo de Campos, Yuan Xiao Zhu, Nikolai Sepetov, Sergei Romanov, Laura Ann Bruins, Chang-Xin Shi, Caleb K. Stein, Joachim L. Petit, Alysia N. Polito, Meaghen E. Sharik, Erin W. Meermeier, Gregory J. Ahmann, Ilsel D. Lopez Armenta, Jonas Kruse, P. Leif Bergsagel, Marta Chesi, Nathalie Meurice, Esteban Braggio, A. Keith Stewart
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
The cellular cytotoxicity of APY0201, a PIKfyve inhibitor, against multiple myeloma was initially identified in an unbiased in vitro chemical library screen. The activity of APY0201 was confirmed in all 25 cell lines tested and in 40% of 100 ex vivo
Externí odkaz:
https://doaj.org/article/36f9707664964168a6cc9caa0c85b080
Autor:
Shaji Kumar, Alysia N. Polito, David Dingli, Esteban Braggio, Nathalie Meurice, Kimberly J. Henderson, Jeremy T. Larsen, P. Leif Bergsagel, Joachim L. Petit, Ilsel D Lopez Armenta, Susie A. Darvish, Greg J. Ahmann, Yuan Xiao Zhu, Craig B. Reeder, Prashant Kapoor, Rafael Fonseca, William Stewart, Xuewei Wang, Jonas J. Kruse, Laura Ann Bruins, A. Keith Stewart, Shulan Tian, Cecília Bonolo de Campos, Panwen Wang
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-16 (2020)
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-16 (2020)
Seventy-six FDA-approved oncology drugs and emerging therapeutics were evaluated in 25 multiple myeloma (MM) and 15 non-Hodgkin’s lymphoma cell lines and in 113 primary MM samples. Ex vivo drug sensitivities were mined for associations with clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216f8e0dfaa638d56d14f713e82745aa
http://europepmc.org/articles/PMC7214452
http://europepmc.org/articles/PMC7214452